Two vials of blue peptide blend powder side by side, one with an extra tripeptide render, representing GLOW versus KLOW
Mindful Research

GLOW vs KLOW: What KPV Adds to the Blend (Composition Comparison)

By: Mindful Research Team3 min read

Key takeaways

  • The only difference between GLOW and KLOW is KPV: KLOW adds 10 mg of the tripeptide Lys-Pro-Val to GLOW's three peptides.
  • GLOW is BPC-157 + TB-500 + GHK-Cu (70 mg); KLOW is the same three at the same masses + KPV (80 mg).
  • KPV adds a cytokine-signaling axis (NF-kB-dependent readouts) to the fibroblast and matrix framing of GLOW.
  • Choose by experimental question: GLOW for a three-peptide matrix model, KLOW when the KPV axis is part of the design.
  • For in vitro research use only.

The difference between GLOW and KLOW is one component: KLOW adds 10 mg of the tripeptide KPV (Lys-Pro-Val, CAS 67727-97-3) to GLOW's BPC-157 (10 mg), TB-500 (10 mg) and GHK-Cu (50 mg), raising the vial from 70 mg to 80 mg and adding a cytokine-signaling axis to the blend's fibroblast and matrix framing. This comparison lays the two compositions side by side, explains what KPV is, and sets out how to choose between the blends for an in vitro design.

GLOW vs KLOW at a glance

Component GLOW (70 mg) KLOW (80 mg) MW (g/mol) Molarity in 1 mL
BPC-157 10 mg 10 mg 1419.5 7.0 mM
TB-500 10 mg 10 mg 4963 2.0 mM
GHK-Cu 50 mg 50 mg 402.92 124 mM
KPV none 10 mg 342.43 29 mM (KLOW only)

Everything in the first three rows is shared. GLOW and KLOW are the same three peptides at the same listed masses; the fourth row is the whole difference. Both are blue lyophilized powders because both contain the GHK-Cu copper complex.

What is KPV?

A tripeptide, Lys-Pro-Val, with the formula C16H30N4O4 and a molecular weight of 342.43 g/mol. Its sequence is the C-terminal fragment, residues 11 to 13, of alpha-melanocyte-stimulating hormone. In cell culture it is studied for its interaction with cytokine-signaling pathways, in particular NF-kB-dependent reporter and cytokine-secretion readouts, which is the research axis it brings to KLOW. KPV is supplied on its own as well, and its profile is KPV: a tripeptide in inflammation research.

What changes when KPV is added?

Three things. The mass goes from 70 to 80 mg, so the stock concentration of the three shared peptides is unchanged at any given volume (they are still 10, 10 and 50 mg per vial) while the solution carries an additional 10 mg/mL of KPV per millilitre. The molar picture shifts: in 1 mL, KLOW has roughly 29 mM KPV on top of GLOW's 7.0 mM BPC-157, 2.0 mM TB-500 and 124 mM GHK-Cu, so the two tripeptides together make up more than 90% of the molecules. And the readout set widens: GLOW is framed for fibroblast, collagen and matrix assays, described in collagen and fibroblast assays; KLOW adds cytokine-pathway readouts, described in cytokine signaling pathways in vitro.

Which blend fits which in vitro design?

GLOW when the question is about the three-peptide matrix model on its own: fibroblast collagen synthesis, metalloproteinase expression, migration in a scratch assay. KLOW when a cytokine-signaling readout is part of the same experiment and the design calls for KPV to be present at a fixed ratio with the other three. In either case the informative comparison is blend versus each single peptide at the molarity it has in the blend, plus a copper-only control, because the blend alone cannot say which component drives a readout. The component profiles are in GLOW peptide blend and KLOW peptide blend.

Do the COAs differ?

By one line set. A GLOW certificate carries three identities and three purities; a KLOW certificate carries four, with an additional mass-spectrometry peak near 342 g/mol for KPV. Either way the per-component data, not a single vial figure, is what confirms the composition; see verifying a multi-component blend COA.

Naming note

Queries phrased as "KLOW vs GLOW peptide" or "difference between GLOW and KLOW peptides" are asking this same composition question, and the answer is always KPV. Neither name is a chemical descriptor; the conventions for describing blends are in multi-peptide research blend terminology.

Related research guides

Research-use note

All materials discussed are supplied for in vitro laboratory research use only, and are not for human or animal use.

Frequently asked questions

What is the difference between GLOW and KLOW peptides?

KPV. GLOW is a blend of BPC-157, TB-500 and GHK-Cu (70 mg); KLOW contains the same three peptides at the same masses plus 10 mg of the tripeptide KPV, for 80 mg. View KLOW

What does KPV add to the blend?

A fourth, very small peptide (Lys-Pro-Val, 342.43 g/mol) studied in cytokine-signaling cell models; by molarity it adds about 29 mM per millilitre of reconstituted stock. View KPV

Are the other three components identical in GLOW and KLOW?

Yes. BPC-157 (10 mg), TB-500 (10 mg) and GHK-Cu (50 mg) are listed at the same masses in both blends.

Which blend should an in vitro design use?

The one that matches the question: GLOW for fibroblast and matrix readouts alone, KLOW when a cytokine-signaling readout is part of the same design. Single-peptide controls are needed with either.

Are GLOW and KLOW for human or animal use?

No. Both are supplied for in vitro laboratory research use only.

Continue reading

Vial of blue copper-complex lyophilized peptide powder in a cold-storage block, representing KLOW 80 mg handling and stabilityKLOW 80 mg: Copper-Complex Blue Lyophilized Powder, Handling, Stability and Stock Concentration Math The KLOW 80 mg vial is a pale-blue lyophilized powder because one of its four components, GHK-Cu, is a copper(II) complex; reconstituted... Researcher in a lab coat checking a vial of blue peptide blend powder against a four-peak analytical readoutSourcing KLOW as a Research Material: Per-Component COA and Purity Sourcing KLOW as a research material means obtaining, in one Certificate of Analysis, the identity and purity data for all four of... Four peptide molecular structures in a row representing the components of the KLOW research blendWhat Is KLOW Peptide? Component-by-Component Breakdown KLOW peptide is not a single peptide: it is a co-formulated research blend of four synthetic peptides, BPC-157 (10 mg), TB-500 (10...